Immunic Inc (NASDAQ:IMUX), a biotech company developing oral therapies for chronic inflammatory and autoimmune diseases, will participate in two upcoming events: BIO-Europe in Vienna, Austria (Nov. 3–5), with CEO Dr. Daniel Vitt and team joining partnering activities, and the Jefferies Global Healthcare Conference in London (Nov. 19–20), where Dr. Vitt and COO Jason Tardio will hold one-on-one investor meetings.